Masimo

July 06, 2021

Role reversal for large-cap medtechs

Shareholders are rewarding the kinds of companies they punished a year ago.

July 02, 2020

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.

April 03, 2020

Joint makers report pandemic pain

Sales of implants are set to fall sharply as non-urgent procedures are deferred.

January 09, 2017

A quiet year for mid-size medtech

July 06, 2016

Masimo

Role reversal for large-cap medtechs

Covid-19 divides the biggest medtechs

Joint makers report pandemic pain

A quiet year for mid-size medtech

Smaller medtechs in charge of their own destiny

Latest Reports

Biopharma and Medtech Half-Year Review 2021

Evaluate Vantage Biopharma and Venture Capital: A Deep Dive

Editor's Picks

Esmo 2021 – Mirati bids to be belle of the ball

World Lung 2021 preview – China challenges and tremelimumab rises

Roche U-turns and Adaptimmune wins

Tecentriq pullout dominates the latest PD-(L)1 moves

Another gene therapy safety scare hits